🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

Showing page 33 of 857 · Phase 3 first, then by program name

  1. Brexanolone

    SUPERNUS PHARMACEUTICALS, INC.

    Post Partum Depression

    phase 3 small molecule completed

    1 trial

  2. Brief Strategic Family Therapy (BSFT)

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Abuse

    phase 3 other completed

    1 trial

  3. Brief advice

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Abuse

    phase 3 other completed

    1 trial

  4. Brief motivational intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Use

    phase 3 other completed

    1 trial

  5. Brigatinib

    Takeda

    ALK+ Advanced NSCLC

    phase 3 small molecule completed

    1 trial

  6. Brigimadlin

    Boehringer Ingelheim

    Liposarcoma, Dedifferentiated

    phase 3 small molecule completed

    1 trial

  7. Brilaroxazine

    REVIVA PHARMACEUTICALS HOLDINGS, INC.

    Schizophrenia

    phase 3 small molecule active

    1 trial

  8. Brincidofovir

    Jazz Pharmaceuticals Ireland Limited

    Cytomegalovirus Disease

    phase 3 small molecule terminated

    2 trials

  9. Brincidofovir

    Jazz Pharmaceuticals Ireland Limited

    Double-stranded DNA Virus

    phase 3 small molecule completed

    1 trial

  10. Brincidofovir

    Jazz Pharmaceuticals Ireland Limited

    CMV

    phase 3 small molecule completed

    1 trial

  11. Brincidofovir

    Jazz Pharmaceuticals Ireland Limited

    Adenovirus Infection

    phase 3 small molecule completed

    1 trial

  12. Brivaracetam

    UCB Pharma

    Epilepsy

    phase 3 small molecule completed

    1 trial

  13. Budesonida Aldo-Unión 0,5 mg/ml suspensión para inhalación por nebulizador, CUROSURF® 120mg/vial + 240mg/vial Endotracheopulmonary Instillation Suspension

    The George Institute

    Bronchopulmonary dysplasia, Preterm newborns ≤32 weeks of gestational age.

    phase 3 small molecule active

    1 trial

  14. Budesonide

    AstraZeneca

    Asthma

    phase 3 small molecule completed

    1 trial

  15. Budesonide

    Bausch + Lomb Ireland Limited

    Colitis, Ulcerative

    phase 3 small molecule completed

    1 trial

  16. Budesonide and formoterol fumarate dehydrate (BF) SPIROMAX

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial

  17. Budesonide oral suspension

    Takeda

    Eosinophilic Esophagitis (EoE)

    phase 3 small molecule terminated

    1 trial

  18. Budesonide/Formoterol SPIROMAX®

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule completed

    1 trial

  19. Budesonide/Formoterol fumarate dihydrate

    Teva Pharma GmbH

    Asthma

    phase 3 small molecule active

    1 trial

  20. Budesonide/formoterol Turbuhaler

    AstraZeneca

    Asthma

    phase 3 small molecule completed

    1 trial

  21. Bufei Yishen granule

    Henan University of Traditional Chinese Medicine

    Chronic Obstructive Pulmonary Disease

    phase 3 small molecule active

    1 trial

  22. Bupivacaine

    United Therapeutics Europe Ltd

    Postoperative Pain

    phase 3 small molecule active

    1 trial

  23. Bupivacaine

    Pacira Ireland Limited

    Malignant Neoplasms of Female Genital Organs

    phase 3 small molecule terminated

    1 trial

  24. Bupivacaine HCl

    Pacira Ireland Limited

    Hemorrhoids

    phase 3 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources